CEBP CTRC-AACR San Antonio Breast Cancer Symposium Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McShane, L. M.
Right arrow Articles by Damato, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McShane, L. M.
Right arrow Articles by Damato, J. J.

Cancer Epidemiology Biomarkers & Prevention, Vol 5, Issue 11 923-928, Copyright © 1996 by American Association for Cancer Research


ARTICLES

Reliability and validity of serum sex hormone measurements

LM McShane, JF Dorgan, S Greenhut and JJ Damato
Biometric Research Branch, National Cancer Institute, Bethesda, Maryland 20892, USA.

The laboratory reliability and validity of sex hormone measurements were examined at multiple levels, including lower levels characteristic of children and postmenopausal women. Serum was drawn from four adult male and four adult female healthy volunteers. From each individual's serum pool, a medium- and a low-dilution pool were created. Biochemical analyses for total and non-sex hormone-binding globulin (SHBG)-bound estradiol, estrone, estrone sulfate, progesterone, and SHBG were performed on female samples. Male samples were analyzed for total and non-SHBG-bound testosterone, dihydrotestosterone, androstenedione, and dehydroepiandrosterone sulfate. Two aliquots from each pool were assayed twice in each of two labs. All assays except SHBG in one lab used RIA procedures. Reliability was assessed by variance components analyses and estimated coefficients of variation (CVs). Validity was assessed by comparing observed measurements versus expected values based on known dilution ratios. For the testosterone and dihydrotestosterone assays, CVs were usually less than 10%. For estradiol and progesterone, CVs were usually less than 15%. Assays with larger estimated CVs included androstenedione, dehydroepiandrosterone sulfate, estrone, and estrone sulfate. Absolute levels differed markedly between labs for most assays. Observed measurements generally agreed with values expected from the dilution ratios. A notable exception was the estrone assay at the lowest dilution level, where observed measurements were 2-4 times those expected. A similar but less pronounced overestimation bias for the low levels of estradiol was also suggested. This intra- and interlaboratory variability and apparent low dilution overestimation should be accounted for in studies relating hormones to cancer risk, especially those involving children and postmenopausal women.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. W. Hsing, F. Z. Stanczyk, A. Belanger, P. Schroeder, L. Chang, R. T. Falk, and T. R. Fears
Reproducibility of Serum Sex Steroid Assays in Men by RIA and Mass Spectrometry
Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 1004 - 1008.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
L. Aksglaede, A. Juul, H. Leffers, N. E. Skakkebaek, and A.-M. Andersson
The sensitivity of the child to sex steroids: possible impact of exogenous estrogens
Hum. Reprod. Update, July 1, 2006; 12(4): 341 - 349.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Tworoger, Y. Yasui, L. Chang, F. Z. Stanczyk, and A. McTiernan
Specimen Allocation in Longitudinal Biomarker Studies: Controlling Subject-Specific Effects by Design
Cancer Epidemiol. Biomarkers Prev., July 1, 2004; 13(7): 1257 - 1260.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
W. A. Colburn
Biomarkers in Drug Discovery and Development: From Target Identification through Drug Marketing
J. Clin. Pharmacol., April 1, 2003; 43(4): 329 - 341.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Rinaldi, H. Dechaud, C. Biessy, V. Morin-Raverot, P. Toniolo, A. Zeleniuch-Jacquotte, A. Akhmedkhanov, R. E. Shore, G. Secreto, A. Ciampi, et al.
Reliability and Validity of Commercially Available, Direct Radioimmunoassays for Measurement of Blood Androgens and Estrogens in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., July 1, 2001; 10(7): 757 - 765.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
M. C. Bosland
Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis
J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 39 - 66.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. Muti
Correspondence re: S. A. Khan et al., The Normal Breast Epithelium of Women with Breast Cancer Displays an Aberrant Response to Estradiol. Cancer Epidemiol. Biomark. Prev., 8: 867-872, 1999
Cancer Epidemiol. Biomarkers Prev., May 1, 2000; 9(5): 535 - 535.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.